SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-086282
Filing Date
2022-08-04
Accepted
2022-08-04 18:24:25
Documents
1
Period of Report
2022-08-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222534-13_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2222534-13_4seq1.xml 4 3643
  Complete submission text file 0001104659-22-086282.txt   5146
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 221138109

Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations